Evidence map›Paper›PMID 42585141›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Downsizing the Histone H3-H4 Quaternary Structure Into Foldamer Mimetics Yields High-Affinity and Cell-Permeable Ligands of ASF1.

Bo Li, Marie E Perrin, Emma Maillard, Arthur Vitard, Gwenaëlle Moal, Johanne Mbianda, Christophe André, Magda Teixeira Nunes, Marie Vandamme, Guillaume Pinna and 6 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bo LiUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.ORCID https://orcid.org/0000-0003-4615-6898
Marie E PerrinInstitute For Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette cedex, France.ORCID https://orcid.org/0000-0002-5917-5177
Emma MaillardInstitute For Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette cedex, France.ORCID https://orcid.org/0009-0000-5452-1600
Arthur VitardInstitute For Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette cedex, France.ORCID https://orcid.org/0009-0001-1843-1293
Gwenaëlle MoalInstitute For Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette cedex, France.ORCID https://orcid.org/0000-0001-5912-7426
Johanne MbiandaUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.ORCID https://orcid.org/0000-0003-2855-573X
Christophe AndréUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.ORCID https://orcid.org/0000-0003-2042-2406
Magda Teixeira NunesHelioBio group, Synchrotron SOLEIL, Saint-Aubin, France.ORCID https://orcid.org/0000-0001-9946-6238
Marie VandammePARi facility, iRCM/IBFJ, Stabilité Génétique Cellules Souches et Radiations, Université Paris Cité, Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.ORCID https://orcid.org/0009-0009-7985-5872
Guillaume PinnaPARi facility, iRCM/IBFJ, Stabilité Génétique Cellules Souches et Radiations, Université Paris Cité, Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.ORCID https://orcid.org/0000-0001-7841-7250
Céline DouatDepartment Pharmazie, Ludwig-Maximilians-Universität München Butenandtstr, München, Germany.ORCID https://orcid.org/0000-0003-2678-1047
Emmanuelle ThinonUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.ORCID https://orcid.org/0000-0001-9248-5655
Raphaël GueroisInstitute For Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette cedex, France.ORCID https://orcid.org/0000-0001-5294-2858
Pierre LegrandHelioBio group, Synchrotron SOLEIL, Saint-Aubin, France.ORCID https://orcid.org/0000-0003-2431-2255
Gilles GuichardUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.ORCID https://orcid.org/0000-0002-2584-7502
Francoise OchsenbeinInstitute For Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette cedex, France.ORCID https://orcid.org/0000-0002-9027-4384

Funding

ANR ANR-20-CE18-0038ANR ANR-21-CE11-0027ANR ANR-23-CE11-0023Conseil Régional de Nouvelle-Aquitaine AAPR2021-2020-11969910Fondation ARC pour la Recherche sur le Cancer PGA1*20160203953French Infrastructure for Integrated Structural Biology ANR-10-INBS-05Inserm Cancer 20CP121-00Inserm Cancer 20CP122-00La Ligue contre le CancerSynchrotron Soleil 20191119Synchrotron Soleil 20210745
6 · The paper itself

Abstract

Mimicking complex protein-protein interfaces with small, well-defined molecular scaffolds remains a major challenge in chemical biology. Here, we report a foldamer-based downsizing strategy that compresses the quaternary architecture of the histone H3-H4 dimer into compact peptide-oligourea hybrids acting as high-affinity ligands of the histone chaperone Anti-Silencing Function 1 (ASF1). Guided by multiple high-resolution co-crystal structures, we designed a series of foldamer mimetics that accurately reproduce both the H3 α-helix and the H4 β-strand epitopes. Systematic optimization of linker geometry, β-strand mimicry, formal charge, and selective backbone N-methylation yielded highly stable ligands with nanomolar affinities, enhanced proteolytic resistance, and robust cytosolic penetration. Notably, the optimized constructs and their N-methylated analogues recapitulate the binding mode of the native H3-H4 dimer on ASF1 with high fidelity and engage endogenous ASF1 in cell extracts, demonstrating effective intracellular target recognition. Together, these results show that peptide-oligourea foldamers can reproduce the structural features of a protein quaternary structure surface, combining high affinity, high stability and cell permeability.

Indexed as

Cell Cycle ProteinsHistonesMolecular ChaperonesHumansLigandsModels, MolecularPeptidesProtein Structure, QuaternaryUreaASF1A protein, humanCell Cycle ProteinsHistonesLigandsMolecular ChaperonesPeptidesUreafoldamer chemistryhistone chaperonepeptideprotein mimicryprotein‐protein interactionsstructure

Identifiers

PMID42585141
PMCPMC13638128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.